Jiangzhong Pharmaceutical releases restricted stock incentive shares
Jiangzhong Pharmaceutical (SSE:600750) announced the upcoming release and listing of 139,938 restricted shares, representing the second unlock period of its 2021 restricted stock incentive plan's reserved portion. The shares will be available for trading on May 30, 2025. This release impacts 14 eligible incentive recipients. The company confirmed that all necessary conditions for the release have been met, aligning with the initial incentive plan and relevant regulations. The original grant price was set at CNY 7.62 per share. Jiangzhong noted that three members, one retirement, one transferred and one resigned, did not meet the terms. The shares will be processed by China Securities Depository and Clearing Corporation Limited, Shanghai Branch. Post release, Jiangzhong Pharmaceutical's unrestricted shares will increase to 627,292,416, while restricted shares will decrease to 1,575,606.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Jiangzhong Pharmaceutical publishes news
Free account required • Unsubscribe anytime